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Within the cortex, nerve growth factor (NGF) mediates the innervation of cholinergic neu-
rons during development, maintains cholinergic corticopetal projections during adulthood
and modulates cholinergic function through phenotypic control of the cholinergic gene
locus. Recent studies suggest NGF may also play an important role in cortical plasticity in
adulthood. Previously, NGF-producing cells have been shown to colocalize with GABAergic
cell markers within the hippocampus, striatum, and basal forebrain. Classiﬁcation of cells
producing NGF in the cortex is lacking, however, and cholinergic corticopetal projections
have been shown to innervate both pyramidal andGABAergic neurons in the cortex. In order
to clarify potential trophic interactions between cortical neurons and cholinergic projections,
we used double-ﬂuorescent immunohistochemistry to classify NGF-expressing cells in
several cortical regions, including the prefrontal cortex, primary motor cortex, parietal
cortex and temporal cortex. Our results show that NGF colocalizes extensively with
GABAergic cell markers in all cortical regions examined, with >91% of NGF-labeled cells
coexpressing GAD65/67. Conversely, NGF-labeled cells exhibit very little co-localizationwith
the excitatory cell marker CaMKIIα (<5% of cells expressing NGF). NGF expression was
present in 56% of GAD-labeled cells, suggesting that production is conﬁned to a speciﬁc
subset of GABAergic neurons. These ﬁndings demonstrate that GABAergic cells are the
primary source of NGF production in the cortex, and likely support the maintenance and
function of basal forebrain cholinergic projections in adulthood.
Keywords: nerve growth factor, basal forebrain, acetylcholine, plasticity, GABAergic, interneuron, protein
expression and localization
INTRODUCTION
The neurotrophin nerve growth factor (NGF) is involved in sev-
eral critical processes in the developing and mature mammalian
nervous system, including target innervation, cell differentiation
and neuronal survival (Large et al., 1986; Li et al., 1995; Sofroniew
et al., 2001; Lad et al., 2003). In the adult brain, NGF plays a key
role in themaintenance and function of the basal forebrain cholin-
ergic system (Lad et al., 2003). Levels of NGF are highest in areas
receiving the greatest number of basal forebrain cholinergic pro-
jections, namely the hippocampus and cortex (Korsching et al.,
1985; Shelton and Reichardt, 1986), and receptors for NGF in the
cortex are largely conﬁned to basal forebrain corticopetal projec-
tions (Kordower et al., 1988; Sofroniew et al., 2001; Rossi et al.,
2002). Nerve growth factor signaling maintains cholinergic cor-
ticopetal projections during adulthood (Chen et al., 1997; Debeir
et al., 1999) and can prevent degeneration of these neurons fol-
lowing transection of their axons (Hefti, 1986; Tuszynski et al.,
1990; Kordower et al., 1994). Furthermore, NGF enhances release
of acetylcholine from basal forebrain cultures (Auld et al., 2001)
and can modulate cholinergic function through phenotypic con-
trol of the cholinergic gene locus (Rylett et al., 1993; Hu et al.,
1997).
The basal forebrain cholinergic system inﬂuences learning
and experience-dependent plasticity in the cortex (Bakin and
Weinberger, 1996; Kilgard and Merzenich, 1998; Conner et al.,
2003, 2005), and NGF signaling has been hypothesized to sup-
port, and possibly enhance, basal forebrain-mediated learning and
plasticity. For example, blockade of NGF signaling via repeated
injections of NGF antibodies in the insular cortex reduces local
cholinergic innervation and disrupts acquisition of two processes
that depend on the integrity of cholinergic inputs, conditioned
taste aversion and inhibitory avoidance learning (Gutierrez et al.,
1997). A recent study by Conner et al. (2009) demonstrated that
both spatial learning and hippocampal long-term potentiation
(LTP) are enhanced following infusions of NGF into the sep-
tal nucleus, the primary source of cholinergic innervation to the
hippocampus.
Focal application of NGF can also induce rapid expansion
of the local whisker representation in the barrel cortex of rats.
This process is dependent on cholinergic projections from the
basal forebrain (Prakash et al., 1996, 2004), suggesting that cor-
tical NGF signaling can stimulate rapid cholinergic-dependent
functional reorganization. Thus, in addition to its long-term
trophic effects on basal forebrain cholinergic cells, NGF may
also participate in short-term circuit remodeling. This “dual-
action” hypothesis is supported by the existence of constitutive
and activity-dependent release mechanisms of NGF (Blochl and
Thoenen, 1995; Lessmann et al., 2003), potentially underlying the
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long-term trophic and short-term modulatory effects of NGF,
respectively. Moreover, both retrograde (long-term) and local
(short-term) signaling pathways have been observed for NGF
(Huang and Reichardt, 2003).
Cells expressing NGF have been detected in the cortex, cere-
bellum, hippocampus, thalamus, striatum, basal forebrain and
brainstem (Gall and Isackson, 1989; Maisonpierre et al., 1990;
Isackson et al., 1991; Conner and Varon, 1992; Hayashi et al.,
1993; Mufson et al., 1994; Zhang et al., 2007). Although NGF
mRNA has been reportedly observed in astrocytes and other
glia, the vast majority of cortical NGF is produced by neurons
(Sofroniew et al., 2001). The speciﬁc types of neurons that pro-
duce NGF in the cortex are not known, however, and cholinergic
corticopetal projections have been shown to innervate both exci-
tatory and inhibitory neurons in the cortex (Zaborszky et al.,
1999). In extracortical regions such as the hippocampus, striatum
and basal forebrain, NGF production is predominantly local-
ized to GABAergic inhibitory neurons (Lauterborn et al., 1993,
1995; Pascual et al., 1998; Bizon et al., 1999). Identiﬁcation of
NGF-producing cells in the cortex is important for identifying
potential mechanisms underlying modulation of cholinergic cor-
tical inputs, and mechanisms of cortical plasticity. In the current
study, we identify a subset of cortical GABAergic cells as the pri-
mary source of NGF production in the adult cortex, with relatively
rare production by glutamatergic neurons.
MATERIALS AND METHODS
All subjects were treated in accordance with institutional guide-
lines for animal care. Due to low endogenous levels of cortical
NGF expression that prohibited identiﬁcation of speciﬁc cell–type
sources of NGF in previous studies, we performed local colchicine
infusions to inhibit microtubule polymerization, thereby block-
ing NGF transport away from the cell body and resulting in
accumulation of detectable NGF antigen in the soma of produc-
ing cells (Schubert et al., 1972; Hokfelt et al., 1975; Hanson and
Edström, 1978; Conner and Varon, 1992). Previous reports have
shown that colchicine treatment increases detection of NGF using
immunohistochemical techniques (Conner andVaron,1992). Fur-
thermore, colchicine levels similar to that used in the current
study do not to induce gross abnormalities in neuronal distri-
bution of the neurotrophin family member BDNF (Conner et al.,
1997).
TISSUE PREPARATION
Eight adult Fischer 344 rats (4 male, 4 female; Harlan Sprague
Dawley) were anesthetized with 2 ml/kg of a 25 mg/ml ketamine,
1.3 mg/ml xylazine, and 0.25 mg/ml acepromazine cocktail, and
injected with 5.0 μl colchicine (10 μg/μl in aCSF) at the cortical
locations listed belowat a rate of 0.5μl/minusing a 10μlHamilton
syringe. Following infusion, the needle remained in place for four
minutes to allow adequate diffusion to the surrounding tissue.
Four animals received bilateral injections in the primary motor
cortex (M1) at +1.2 mm anterior (A/P) and ±2.5 mm lateral
(M/L) to bregma. Half the solution was injected at 1.6 mm below
the surface of the brain (D/V), and the rest at 1.0 mm. The remain-
ing four animals all received unilateral injections in the prefrontal
cortex (A/P: +3.0, M/L: +0.5, D/V: −2.3 and −1.8), temporal
cortex (A/P: −6.5, M/L: +5.0, D/V: −7.5 and −7.0), and pari-
etal cortex (A/P: −3.0, M/L: +5.0, D/V: −1.8 and −1.3). After
48 h, animals were deeply anesthetized and transcardially perfused
with 250 ml cold phosphate buffered saline (pH 7.4), followed by
250 ml of cold 2% paraformaldehyde + 0.2% parabenzoquinone
in 0.1 M phosphate buffer. Brains were extracted, postﬁxed for
2 h in the same ﬁxative, and cryoprotected in 0.1 M phosphate
buffer containing 30% sucrose for at least 72 h at 4◦C. Coronal
sections (40 μm) were cut on a freezing sliding microtome and
stored in cryoprotectant (TCS) at 4◦C until further processed for
immunohistochemistry.
DOUBLE-LABEL FLUORESCENCE IMMUNOHISTOCHEMISTRY
Sequential double-label immunohistochemistry was used to visu-
alize neurons expressing NGF and either GABAergic or gluta-
matergic cell markers. Free-ﬂoating sections were washed in Tris
Buffered Saline (TBS), permeabilized with 0.25% Triton X-100,
and nonspeciﬁc labeling was then blocked with 5% donkey serum.
Sections were incubated for 72 h at 4◦C in rabbit anti-NGF anti-
body (Conner and Varon, 1992) diluted 1:1000 in TBS, 0.25%
Triton X-100, and 5% donkey serum. Following primary anti-
body incubation, sections were incubated in donkey anti-rabbit
biotin-conjugated IgG (1:200; Vector Laboratories, Burlingame,
CA, USA). Tyramide signal ampliﬁcation (TSA; PerkinElmer,
Waltham, MA, USA) was applied to amplify the NGF signal,
after which sections were washed in TBS and incubated in Alexa
Fluor 488 or 594-conjugated streptavidin (Invitrogen, Carlsbad,
CA, USA) diluted 1:200 for 3 h at 4◦C. After a brief wash,
sections were incubated in both mouse anti-glutamate decarboxy-
lase (GAD) 65 (GAD-6, AntibodyRegistry:AB_528264,1:2000;
Developmental Studies Hybridoma Bank, Iowa City, IA, USA)
and mouse anti-GAD67 (AnitbodyRegistry: AB_2278725, 1:1500;
Millipore, Temecula, CA, USA), or in mouse anti-parvalbumin
(AntibodyRegistry: AB_2174013, 1:30000; Millipore, Temec-
ula, CA, USA), mouse anti-calbindin-D-28K (AntibodyRegistry:
AB_476894, 1:1500; Sigma-Aldrich, St. Louis, MO, USA),
or mouse anti-Ca2+/calmodulin-dependent protein kinase IIα
(CaMKIIα, AntibodyRegistry: AB_2067919, 1:1500; Millipore)
for 72 h at 4◦C. Finally, sections were washed, incubated in
Alexa Fluor 594 or 488-conjugated donkey anti-mouse (Invit-
rogen) for 3 h at room temperature, washed again, mounted
on glass slides, and coverslipped in Fluoromount-G (Southern
Biotech, Birminghan, AL, USA). In order to maximize iden-
tiﬁcation of GABAergic cells, GAD65 and GAD67 antibodies
were co-incubated. A subset of sections was coverslipped in
ProLong Gold with DAPI (Invitrogen) for visualization of cell
nuclei.
ANTIBODY CHARACTERIZATION
The NGF antibody used in this study is an afﬁnity-puriﬁed poly-
clonal raised in rabbit against puriﬁed mouse NGF (Conner
and Varon, 1992). The antibody recognizes puriﬁed mouse and
recombinant human NGF but does not cross react with recom-
binant BDNF or NT-3 (Conner and Varon, 1996). Furthermore,
the immunoreactive pattern of NGF expression in the rat brain
closely matches that obtained from in-situ analysis in the rat brain
(Conner and Varon, 1997).
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The monoclonal antibody GAD-65 (Developmental Studies
HybridomaBank,Gad-6) was produced by immunizingmice with
GAD protein immunoafﬁnity-puriﬁed from rat brain. Western
blot analysis of rat brain homogenates revealed the antibody selec-
tively recognizes GAD-65 but not GAD-67 (Chang and Gottlieb,
1988). Additional studies have shown that the GAD-6 antibody
recognizes an epitope located between amino acids 475–571 of the
C-terminus of GAD-65 (Butler et al., 1993).
The GAD-67 mouse monoclonal (Millipore, MAB 5406, lot:
25010139) was raised against amino acid residues 4-101 of human
GAD-67, and recognizes a single 67-kDa band on Western blot
analysis of rat brain (manufacturer’s technical information).
Preincubation of the antibody with a GST-GAD-67 fusion pro-
tein resulted in no immunopositive signal in the brain (Ito et al.,
2007).
The mouse monoclonal anti-CaMKIIα (Millipore, MAB 8699,
lot: LV1366080) speciﬁcally recognizes the alpha subunit of
calcium/calmodulin-dependent protein kinase II. Western blot
analysis demonstrates that the antibody identiﬁes a single band
of 50 kDa and recognizes both phosphorylated and unphospho-
rylated forms (Erondu and Kennedy, 1985).
Monoclonal anti-calbindin-D-28k (Sigma–Aldrich, C9848, lot:
088k4799) is derived from BALB/c mice immunized with puri-
ﬁed bovine kidney calbindin-D-28k. Immunoblotting showed
the antibody recognizes a 28-kDa band, and does not to
react with similar molecules, such as calbindin-D-9K, calre-
tinin, myosin light chain, and parvalbumin (manufacturer’s
technical information). Preabsorption with a calbindin-D-27 kDa
protein puriﬁed from chick and rat brains was shown to elim-
inate calbindin immunostaining in the brain (Pasteels et al.,
1987).
Anti-parvalbumin (Millipore, MAB 1572, lot: LV1378387)
was collected from mice immunized against parvalbumin puri-
ﬁed from frog muscle. The monoclonal antibody is directed
against an epitope at the ﬁrst Ca2+-binding site and immunoblot
analysis demonstrates it recognizes a brain protein of 12 kDa
(manufacturer’s technical information).
CONFOCAL ANALYSIS
Images were captured using an Olympus AX70 with Magnaﬁre
software (version 2.0; Karl Storz Imaging, Goleta, CA, USA).
Because NGF labeling was reduced substantially approximately
2 mm anterior/posterior to colchicine injection sites, presumably
due to a lack of colchicine diffusion and the resulting absence
of somatic NGF accumulation, only sections within 1.5 mm of
each colchicine injection site were analyzed. Every 10th section
(400 μm) was examined within a cortical region. Cells were
manually counted, and at least three sections were analyzed
in each cortical region and antibody combination per subject.
Only three animals were evaluated in the temporal region due
to undetectable NGF labeling in the fourth. Single and double-
labeled cells were quantiﬁed using both single and double-channel
images. Several criteria were used to identify labeled cells, includ-
ing size, morphology, signal vs. background, and coincident
DAPI labeling when assessing DAPI-stained tissue. In a sub-
set of sections, 5 μm z-stacks were collected using an Olympus
Fluoview FV1000 to ensure neuronal localization of the labeled
object. Due to our interest in the proportion, and not the absolute
number, of double-labeled cells, stereological methods were not
used.
The percentage of double-labeled cells per immunoreactive
(IR) cell group was determined for each image ﬁeld. Mean ± stan-
dard error was calculated for each cortical region examined.
One-way analysis of variance (ANOVA) was used to evaluate
differences among cortical regions. Fisher’s HSD was used for
post-hoc analysis. All statistical analyses were carried out with
SPSS 15.0 for Windows.
ANTIBODY CONTROLS
Controls included omission of primary antibodies, omission of
secondary antibodies, and replacement of primary antibody with
nonspeciﬁc antibody (rabbit IgG). All manipulations had the
expected effects and supported the assertion that labeled cells
represent true antigen labeling by their corresponding antibodies.
RESULTS
NGF IMMUNOLABELING
Distinct NGF labeling was visible within a radius of 1.5 mm
from colchicine cortical injection sites. Within these areas, NGF
labeling was predominantly conﬁned to cell somata (Figure 1).
Rarely, one or more cellular processes could also be distinguished.
Outside of this 1.5 mm radius, NGF labeling was virtually unde-
tectable in the cortex. As cortical expression of the NGF receptors
TrkA and p75 are conﬁned to cholinergic corticopetal ﬁbers, the
observed labeling of NGF is unlikely to reﬂect endocytosed NGF,
but instead is indicative of NGF-producing cells (Holtzman et al.,
1995; Rossi et al., 2002; Stephens et al., 2005). As reported previ-
ously (Ribak et al., 1978), colchicine treatment intensiﬁed GAD
labeling in cell bodies as well as neuronal processes. Colchicine
had no detectable effect on labeling for parvalbumin, calbindin,
or CaMKIIα.
NGF AND GABAergic CO-LOCALIZATION
Nerve growth factor co-localized extensively with the GABAer-
gic cell markers GAD65 and GAD67, regardless of the cortical
area examined (Figure 1; Table 1). Overall, 91 ± 0.9% of NGF-
labeled cortical cells also labeled for GAD65/67. The percentage
of NGF-labeled cells co-expressing GAD65/67 showed little differ-
ence among the prefrontal (90.0 ± 1.5%), motor (91.7 ± 1.5%),
parietal (89.6 ± 3.5%) and temporal (93.4 ± 8.1%) cortices (one-
way ANOVA; p = 0.78). Conversely, NGF co-localized with only
55± 2.3%of allGAD65/67-labeled cells. Todetermine if NGFpro-
duction was restricted to a speciﬁc subtype of GABAergic neuron,
we co-labeled tissue for NGF and either parvalbumin or cal-
bindin (Figure 2). NGF-labeled cells were observed to colocalize
with both markers. However, NGF colocalization with parval-
bumin (67.8 ± 3.6%) was over 2× greater than with calbindin
(29.1 ± 3.9%). Additionally, NGF-IR cells constituted less than
half of all parvalbumin (47.7± 4.6%) and calbindin (25.7± 4.9%)
immunoreactive cells.
Nerve growth factor-expressing neurons were observed
throughout all cortical layers. Previous studies have reported
uneven distribution of NGF-labeled neurons in the cortical lam-
inae (Pitts and Miller, 2000; Patz and Wahle, 2006). Quantitative
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FIGURE 1 | Nerve growth factor colocalizes extensively with inhibitory
cell markers. Immunoreactive cells in the (A) primary motor cortex and
(B) prefrontal cortex. Images show that NGF-labeled cells (green)
colocalize extensively with GAD 65/67-labeled cells (red). White arrows
show an example cell immunoreactive for both NGF and GAD 65/67 in
each cortical region. Blue arrows show cells immunoreactive for GAD
65/67 only. (C) Magniﬁed image of area inside white box in (B).
(D) X –Y –Z reconstruction of the double-labeled cell indicated in (C). Green
and Blue lines indicate dissection levels in XZ and YZ planes, respectively.
Scale bars = 25 μm.
Table 1 | NGF- and GAD65/67-immunoreactive cells by cortical region.
Cortical region NGF I.R. cells GAD65/67 I.R. cells Double I.R. cells % NGF double I.R. % GAD65/67 double I.R.
Prefrontal 180 312 163 90.0 ± 1.5 52.2 ± 1.6
Motor 530 830 486 91.7 ± 1.5 58.5 ± 2.2
Parietal 134 247 120 89.6 ± 3.5 48.6 ± 5.1
Temporal 61 100 57 93.4 ± 8.1 57.0 ± 7.3
Total 905 1489 826 91.3 55.5
analysis by layer was not performed in the current study, however,
as NGF labeling intensity diminished with increasing distance
from the colchicine injection site.
NGF AND GLUTAMATERGIC CO-LOCALIZATION
Labeling for CaMKIIα was primarily observed within cell
somata and proximal processes (Figure 3). Unlike the exten-
sive co-localization seen with NGF and GABAergic markers,
NGF-labeled cells rarely co-localized with CaMKIIα-labeled
cells (Figure 3; Table 2). In total, 4.9 ± 1.1% of NGF-
immunoreactive cells were co-labeled with CaMKIIα antibodies.
Co-localization differed signiﬁcantly by cortical region (one-
way ANOVA; p = 0.03); Fisher’s post hoc revealed that the
prefrontal cortex had a greater proportion of double-labeled
NGF cells (7.6 ± 2.1%) compared to the primary motor cor-
tex (2.4 ± 1.0%; p = 0.02) and parietal cortex (2.9% ± 1.5;
p = 0.01).
Cells immunoreactive for CaMKIIα greatly outnumbered
those labeled by NGF antibodies. The overall proportion of
CaMKIIα-labeled cells simultaneously expressing NGF signal
was 2 ± 0.6%. This percentage differed signiﬁcantly by region
(one-way ANOVA p = 0.003), with the prefrontal cortex exhibit-
ing a greater proportion of double-labeled NGF/CaMKIIα cells
(3.7 ± 1.1%) than the primary motor cortex (0.8% ± 0.3;
p = 0.001), the parietal cortex (1.4% ± 0.6; p = 0.01), and the
temporal cortex (1.5 ± 0.6%; p = 0.01).
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FIGURE 2 | NGF colabeled with inhibitory neuron subclass markers. Slices of the motor cortex were labeled for NGF and either parvalbumin or calbindin.
(A) Cells showed extensive overlap of NGF and parvalbumin labeling (white arrows). (B) Conversely, colabeling of NGF and calbindin was less common. Scale
Bars = 25 μm.
FIGURE 3 | Nerve growth factor colocalizes minimally with the
excitatory cell marker CaMKIIα. Immunoreactive cells in the prefrontal
cortex. Cells were rarely colabeled for NGF (green) and CaMKIIα (red),
regardless of cortical region examined. Gold arrows show an example of a
cell immunoreactive for NGF only. Scale bars = 25 μm.
DISCUSSION
The current study demonstrates that the vast majority (>90%)
of NGF-producing neurons of the cortex are GABAergic, while
half of all GABAergic neurons colocalize with NGF. In contrast,
markers of excitatory neurons exhibit only rare co-localization
with NGF. These results were consistent throughout multiple
cortical regions analyzed in this study, indicating that NGF
is primarily produced by inhibitory interneurons in the rat
neocortex.
Although NGF immunoreactivity rarely coincided with exci-
tatory cell markers (CAMKIIα), a small percentage (∼5%) were
positive for CaMKIIα throughout all examined cortical regions.
Confocal analysis conﬁrmed that this double labeling originated
from the same focal plane, and was not due to discrete signal
arising from overlapping cells. The functional signiﬁcance of NGF
expression in such a small fraction of excitatory cells in not known
but it is possible that these NGF-producing neurons represent
a previously unidentiﬁed subclass of excitatory neurons in the
neocortex.
Our results are consistent with ﬁndings of earlier studies in
other brain regions demonstrating that NGF co-localizes almost
exclusively with GABAergic cells in the striatum, basal forebrain,
and hippocampus (Lauterborn et al., 1993, 1995; Pascual et al.,
1998; Bizon et al., 1999). Thus, NGF production by GABAer-
gic cells may be a general property of all targets receiving basal
forebrain cholinergic innervation (including the basal forebrain
itself). These cholinergic neuronal populations require NGF for
maintenance of their phenotype and projections (Rylett et al.,
1993; Chen et al., 1997; Hu et al., 1997; Debeir et al., 1999).
Across studies, inhibitory interneurons now emerge as the pri-
mary source of NGF trophism for basal forebrain cholinergic
neurons.
Although basal forebrain cholinergic neurons innervate both
excitatory and inhibitory cortical networks (Zaborszky et al.,
1999), the source of trophic support is overwhelmingly from
the inhibitory population, which is known to play a critical
role in mediating plasticity in cortical circuits (Hensch and
Stryker, 2004; Yazaki-Sugiyama et al., 2009; Donato et al., 2013).
Cholinergic signaling appears to contribute to the differential acti-
vation of various inhibitory subpopulations, thereby modulating
excitatory-inhibitory balance (Xiang et al., 1998; Froemke et al.,
2007). NGF may thereby serve as a feedback signal between highly
plastic inhibitory networks and the cholinergic inputs that activate
them. Indeed, NGF augments plasticity and behavioral learn-
ing through cholinergic-dependent mechanisms (Prakash et al.,
1996, 2004; Gutierrez et al., 1997; Conner et al., 2009). Activity-
dependent release of NGF (Blochl and Thoenen, 1995; Lessmann
et al., 2003), paired with the ability of NGF to increase cholinergic
activity (Rylett et al., 1993; Hu et al., 1997; Auld et al., 2001), sug-
gests that NGF may promote reorganization of active circuits via
enhanced cholinergic function.
Table 2 | NGF- and CaMKIIα-immunoreactive cells by cortical region.
Cortical region NGF I.R. cells CaMKIIa I.R. cells Double I.R. cells % NGF double I.R. % CaMKIIa double I.R.
Prefrontal 317 649 24 7.6 ± 2.1 3.7 ± 1.1
Motor 125 380 3 2.4 ± 1.0 0.8 ± 0.3
Parietal 240 508 7 2.9 ± 1.5 1.4 ± 0.6
Temporal 182 519 8 4.4 ± 1.6 1.5 ± 0.6
Total 864 2056 42 4.9 2.0
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Future studies will attempt to identify which subclasses of
inhibitory neurons express NGF and how this expression pre-
cisely inﬂuences cortical circuitry. To this end,we took preliminary
steps to determine whether NGF co-localized with two common
markers of inhibitory neurons, parvalbumin (primarily associ-
ated with basket and chandelier cells), and calbindin (associated
with numerous inhibitory cell types; McBain and Fisahn, 2001;
Markram et al., 2004). Our results demonstrate that NGF was pri-
marily detected in parvalbumin-immunoreactive cells, although
many cells labeledbyparvalbumindidnot co-expressNGF. Impor-
tantly, NGF-IR cells also colocalized with calbindin-labeled cells,
suggesting that more than one subclass of inhibitory neuron
produces NGF.
In summary, within the rat neocortex NGF is primarily
expressed by inhibitory neurons, a property that appears to be
conserved from phylogenetically older brain areas and which may
generalize to the brain as a whole. Our results suggest cortical
inhibitory interneurons play a vital role in the maintenance of
cholinergic projection neurons of the basal forebrain. GABAer-
gic interneurons thus may promote cortical reorganization via
regulated NGF signaling.
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